ArticleCell death & disease2022

Targeted activation of GPER enhances the efficacy of venetoclax by boosting leukemic pyroptosis and CD8+ T cell immune function in acute myeloid leukemia.

Jun Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.